Daniel Aradi

Summary

Publications

  1. doi request reprint Optimizing P2Y12 Receptor Inhibition in Patients With Acute Coronary Syndrome on the Basis of Platelet Function Testing: Impact of Prasugrel and High-Dose Clopidogrel
    Daniel Aradi
    Department of Cardiology, Heart Center Balatonfüred, Balatonfured, Hungary Electronic address
    J Am Coll Cardiol 63:1061-70. 2014
  2. doi request reprint Current evidence for monitoring platelet reactivity in acute coronary syndrome: a plea for individualized antiplatelet treatment
    Daniel Aradi
    University of Pecs, Heart Institute, Hungary
    Int J Cardiol 167:1794-7. 2013
  3. doi request reprint Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis
    Daniel Aradi
    University of Pecs, Heart Institute, Pecs, Hungary
    Int J Cardiol 167:2140-8. 2013
  4. doi request reprint Impact of clopidogrel and potent P2Y 12 -inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a systematic review and meta-analysis
    Daniel Aradi
    University of Pecs, Heart Institute, Division of Interventional Cardiology, Hungary
    Thromb Haemost 109:93-101. 2013
  5. doi request reprint Platelet function monitoring in patients on clopidogrel: What should we learn from GRAVITAS?
    Daniel Aradi
    Department of Interventional Cardiology, Heart Institute, University of Pecs, Hungary
    Platelets 23:167-76. 2012
  6. doi request reprint Justification of 150 mg clopidogrel in patients with high on-clopidogrel platelet reactivity
    Daniel Aradi
    Heart Institute, University of Pecs, Pecs, Hungary
    Eur J Clin Invest 42:384-92. 2012
  7. doi request reprint Inter-patient variability and impact of proton pump inhibitors on platelet reactivity after prasugrel
    Daniel Aradi
    University of Pecs, Heart Institute, Division of Interventional Cardiology, Hungary
    Thromb Haemost 107:338-45. 2012
  8. doi request reprint Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis
    Daniel Aradi
    University of Pecs, Heart Institute, Hungary
    Am Heart J 160:543-51. 2010
  9. doi request reprint Comparison of conventional aggregometry with VASP for monitoring P2Y12-specific platelet inhibition
    Daniel Aradi
    Department of Interventional Cardiology, Heart Institute, University of Pecs, Hungary
    Platelets 21:563-70. 2010
  10. doi request reprint Impact of genetic variants on post-clopidogrel platelet reactivity in patients after elective percutaneous coronary intervention
    Orsolya Rideg
    Institute of Laboratory Medicine, University of Pecs, 13 Ifjúság Street, H 7624 Pecs, Hungary
    Pharmacogenomics 12:1269-80. 2011

Collaborators

Detail Information

Publications15

  1. doi request reprint Optimizing P2Y12 Receptor Inhibition in Patients With Acute Coronary Syndrome on the Basis of Platelet Function Testing: Impact of Prasugrel and High-Dose Clopidogrel
    Daniel Aradi
    Department of Cardiology, Heart Center Balatonfüred, Balatonfured, Hungary Electronic address
    J Am Coll Cardiol 63:1061-70. 2014
    ....
  2. doi request reprint Current evidence for monitoring platelet reactivity in acute coronary syndrome: a plea for individualized antiplatelet treatment
    Daniel Aradi
    University of Pecs, Heart Institute, Hungary
    Int J Cardiol 167:1794-7. 2013
    ..The aim of this viewpoint article is to summarize the currently available evidence supporting a role of platelet function testing in patients with ACS after PCI. ..
  3. doi request reprint Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis
    Daniel Aradi
    University of Pecs, Heart Institute, Pecs, Hungary
    Int J Cardiol 167:2140-8. 2013
    ..We aimed to determine the efficacy and safety of giving intensified antiplatelet therapy on the basis of platelet reactivity testing for patients undergoing percutaneous coronary intervention (PCI)...
  4. doi request reprint Impact of clopidogrel and potent P2Y 12 -inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a systematic review and meta-analysis
    Daniel Aradi
    University of Pecs, Heart Institute, Division of Interventional Cardiology, Hungary
    Thromb Haemost 109:93-101. 2013
    ....
  5. doi request reprint Platelet function monitoring in patients on clopidogrel: What should we learn from GRAVITAS?
    Daniel Aradi
    Department of Interventional Cardiology, Heart Institute, University of Pecs, Hungary
    Platelets 23:167-76. 2012
    ..This article aims to review the available evidence regarding the clinical relevance of platelet function monitoring, highlighting possible reasons for the controversy between guidelines and observational studies...
  6. doi request reprint Justification of 150 mg clopidogrel in patients with high on-clopidogrel platelet reactivity
    Daniel Aradi
    Heart Institute, University of Pecs, Pecs, Hungary
    Eur J Clin Invest 42:384-92. 2012
    ..We aimed to determine the impact of 150 mg clopidogrel in stable angina patients with HPR identified with conventional aggregometry (LTA)...
  7. doi request reprint Inter-patient variability and impact of proton pump inhibitors on platelet reactivity after prasugrel
    Daniel Aradi
    University of Pecs, Heart Institute, Division of Interventional Cardiology, Hungary
    Thromb Haemost 107:338-45. 2012
    ..The 60 mg loading dose is superior to conventional and reduced maintenance doses in terms of platelet reactivity inhibition and regarding the prevention of HPR...
  8. doi request reprint Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis
    Daniel Aradi
    University of Pecs, Heart Institute, Hungary
    Am Heart J 160:543-51. 2010
    ..We aimed to perform an updated systematic review and meta-analysis on the clinical relevance of HPR to summarize the available evidence and to define more precise effect estimates...
  9. doi request reprint Comparison of conventional aggregometry with VASP for monitoring P2Y12-specific platelet inhibition
    Daniel Aradi
    Department of Interventional Cardiology, Heart Institute, University of Pecs, Hungary
    Platelets 21:563-70. 2010
    ..These results reject a commonly used hypothesis and might contribute to the standardization of the LTA assay...
  10. doi request reprint Impact of genetic variants on post-clopidogrel platelet reactivity in patients after elective percutaneous coronary intervention
    Orsolya Rideg
    Institute of Laboratory Medicine, University of Pecs, 13 Ifjúság Street, H 7624 Pecs, Hungary
    Pharmacogenomics 12:1269-80. 2011
    ..To determine the effect of various SNPs on post-clopidogrel platelet reactivity and clinical outcome...
  11. doi request reprint Thienopyridine therapy influences late outcome after coronary stent implantation
    Daniel Aradi
    Department of Interventional Cardiology, Heart Institute, University of Pecs, Pecs, Hungary
    Angiology 59:172-8. 2008
    ....
  12. doi request reprint Low platelet disaggregation predicts poor response to 150 mg clopidogrel in patients with elevated platelet reactivity
    Daniel Aradi
    Department of Interventional Cardiology, Heart Institute, University of Pecs
    Platelets 21:1-10. 2010
    ..Acute coronary syndrome and low (<16.5%) platelet disaggregation are independent predictors of poor benefit from dose shift...
  13. doi request reprint Outcomes of patients receiving clopidogrel prior to cardiac surgery
    András Vorobcsuk
    University of Pecs, Heart Institute, Department of Cardiovascular Intensive Care, Hungary
    Int J Cardiol 156:34-40. 2012
    ..We aimed to pool and systematically analyze outcomes in clopidogrel-treated patients undergoing cardiac operations to achieve greater statistical power and to define precise effect-estimates...
  14. doi request reprint Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction Systematic overview and meta-analysis
    András Vorobcsuk
    Heart Institute, University of Pecs, Hungary
    Am Heart J 158:814-21. 2009
    ..Our aim was to assess the safety and efficacy of TRPCI versus transfemoral PCI in the context of treating patients suffering acute myocardial infarction with STEMI...
  15. doi request reprint Use of new-generation oral anticoagulant agents in patients receiving antiplatelet therapy after an acute coronary syndrome: systematic review and meta-analysis of randomized controlled trials
    Andras Komocsi
    Department of Interventional Cardiology, Heart Institute, University of Pecs, Pecs, Hungary
    Arch Intern Med 172:1537-45. 2012
    ..Our study objective was to evaluate the efficacy and safety of new-generation oral anticoagulant agents compared with placebo in patients receiving antiplatelet therapy after an ACS...